Health Care & Life Sciences » Biotechnology | Bellicum Pharmaceuticals Inc.

Bellicum Pharmaceuticals Inc.

Bellicum Pharmaceuticals Inc.
Stock Exchange NASDAQ Stock Market
EPS
$2.33
Market Cap
$80.98 M
Shares Outstanding
46.01 M
Public Float
39.9 M

Profile

Address
Life Science Plaza
Houston Texas 77030
United States
Employees -
Website http://www.bellicum.com
Updated 07/08/2019
Bellicum Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on discovering and developing cellular immunotherapies for cancers and orphan inherited blood disorders. It uses its proprietary chemical induction of dimerization that controls components of the immune system in real time. The company was founded by Kevin M.

Financials

View All

Richard A. Fair
President, Chief Executive & Financial Officer
James Farrell Brown
Chairman